BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 35088888)

  • 1. GATA6‑induced FN1 activation promotes the proliferation, invasion and migration of oral squamous cell carcinoma cells.
    Zhai J; Luo G
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35088888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC00173 blocks GATA6-mediated transcription of COL5A1 to affect malignant development of oral squamous cell carcinoma.
    Dong C; Zhao Y; Yang S; Jiao X
    J Oral Pathol Med; 2023 Jul; 52(6):493-503. PubMed ID: 36856154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA6 regulates expression of annexin A10 (ANXA10) associated with epithelial-mesenchymal transition of oral squamous cell carcinoma.
    Takayama S; Morita Y; Nishimoto A; Nishimura J; Takebe K; Kishimoto S; Matsumiya-Matsumoto Y; Matsunaga K; Imai T; Uzawa N
    Arch Oral Biol; 2022 Dec; 144():105569. PubMed ID: 36265396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L; Cheng J; Li A
    Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
    [No Abstract]   [Full Text] [Related]  

  • 5. BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.
    Shan F; Shen S; Wang X; Chen G
    Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36929425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA PVT1 promotes tumor cell proliferation, invasion, migration and inhibits apoptosis in oral squamous cell carcinoma by regulating miR‑150‑5p/GLUT‑1.
    Li X; Ren H
    Oncol Rep; 2020 Oct; 44(4):1524-1538. PubMed ID: 32945498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLC2A3 promotes tumor progression through lactic acid-promoted TGF-β signaling pathway in oral squamous cell carcinoma.
    Jiang W; Xu S; Li P
    PLoS One; 2024; 19(4):e0301724. PubMed ID: 38625978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.
    Zhang AM; Chi XH; Bo ZQ; Huang XF; Zhang J
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31439759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma.
    Morita Y; Hata K; Nakanishi M; Omata T; Morita N; Yura Y; Nishimura R; Yoneda T
    Clin Exp Metastasis; 2015 Oct; 32(7):739-53. PubMed ID: 26319373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis.
    Peng Y; Yin D; Li X; Wang K; Li W; Huang Y; Liu X; Ren Z; Yang X; Zhang Z; Zhang S; Fan T
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6097-6113. PubMed ID: 36656379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
    Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
    Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
    Yang K; Zhao J; Liu S; Man S
    Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltage-gated sodium channel Nav1.5 promotes proliferation, migration and invasion of oral squamous cell carcinoma.
    Zhang J; Mao W; Dai Y; Qian C; Dong Y; Chen Z; Meng L; Jiang Z; Huang T; Hu J; Luo P; Korner H; Jiang Y; Ying S
    Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):562-570. PubMed ID: 31139826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLAU, transcriptionally negatively regulated by GATA6, promotes lung squamous carcinoma cell proliferation and migration.
    Guo J; Wang H; Huang C; Lai C; Shang W; Luo S; Chen L
    Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119744. PubMed ID: 38702016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA SNHG20 regulates cell migration, invasion, and proliferation via the microRNA-19b-3p/RAB14 axis in oral squamous cell carcinoma.
    Zhu X; Zhang H; Xu J
    Bioengineered; 2021 Dec; 12(1):3993-4003. PubMed ID: 34282711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
    Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
    Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
    Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J
    BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine hydroxymethyltransferase 2 (SHMT2) potentiates the aggressive process of oral squamous cell carcinoma by binding to interleukin enhancer-binding factor 2 (ILF2).
    Zhang H; Che Y; Xuan B; Wu X; Li H
    Bioengineered; 2022 Apr; 13(4):8785-8797. PubMed ID: 35333683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).
    Dong Y; Xue L; Zhang Y; Liu C; Zhang Y; Jiang N; Ma X; Chen F; Li L; Yu L; Liu X; Shao S; Guan S; Zhang J; Xiao Q; Li H; Dong A; Huang L; Shi C; Wang Y; Fu M; Lv N; Zhan Q
    J Exp Clin Cancer Res; 2022 Apr; 41(1):150. PubMed ID: 35449073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.